Chronic p38 mitogen-activated protein kinase inhibition improves vascular function and remodeling in angiotensin II-dependent hypertension
Introduction: An excess of angiotensin II (Ang II) causes hypertension and vascular injury. Activation of mitogen-activated protein kinase p38 (p38-MAPK) plays a substantial role in Ang II-dependent organ damage. Recently, we showed that p38-MAPK activation regulates the pressor response to Ang II....
Main Authors: | SA Potthoff, S Stamer, K Grave, E Königshausen, SH Sivritas, M Thieme, Y Mori, M Woznowski, LC Rump, J Stegbauer |
---|---|
Format: | Article |
Language: | English |
Published: |
SAGE Publications
2016-07-01
|
Series: | Journal of the Renin-Angiotensin-Aldosterone System |
Online Access: | https://doi.org/10.1177/1470320316653284 |
Similar Items
-
Effects of p38 mitogen-activated protein kinase inhibition on vascular and systemic inflammation in patients with atherosclerosis.
by: Elkhawad, M, et al.
Published: (2012) -
The effect of angiotensin II on mitogen-activated protein kinase in human cardiomyocytes
by: Chiming Wei, et al.
Published: (2000-12-01) -
p38 mitogen‐activated protein kinase: Functions and targeted therapy in diseases
by: Qinwen Zheng, et al.
Published: (2023-09-01) -
Post-transcriptional regulation of gene expression by mitogen-activated protein kinase p38.
by: Clark, A, et al.
Published: (2003) -
Safety and efficacy of p38 mitogen-activated protein kinase inhibitors (MAPKIs) in COPD
by: Haichuan Yu, et al.
Published: (2022-09-01)